Junshi Biosciences gets Chinese approval
for emerging therapy to treat skin cancer.
A Shanghai Co. has nabbed China's first
approval for a homegrown anti-PD-1 treatment, an emerging cancer therapy that
boosts the immune system to help the body to target and kill tumors.